Predictive Oncology Q2 EPS $(0.98) Up From $(3.00) YoY, Sales $490.11K Up From $371.59K YoY
Portfolio Pulse from bharat@benzinga.com
Predictive Oncology (NASDAQ:POAI) reported Q2 losses of $(0.98) per share, a 67.33% increase from $(3.00) per share YoY. The company also reported a 31.90% increase in sales to $490.11K from $371.59K YoY.
August 10, 2023 | 9:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Predictive Oncology reported improved Q2 results with reduced losses and increased sales YoY.
Predictive Oncology's Q2 results show a significant improvement from the same period last year. The company's losses have reduced by 67.33% and sales have increased by 31.90%. This positive financial performance could potentially lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100